Ro Body Review – FDA-Approved GLP-1s at Real Prices, With a Membership Attached

Ro is a US telehealth company founded in 2017 and headquartered in New York, running a vertically integrated platform that combines telemedicine, diagnostics, labs and pharmacy. Its Ro Body programme is for people who want weight-loss medication without an insurance requirement or an in-person visit. What makes it worth a fresh look is that Ro now sells FDA-approved GLP-1s at prices that compete with the compounded market — the Wegovy pill from $149 a month — which sidesteps the regulatory uncertainty hanging over most cheap GLP-1 programmes. The catch is a membership fee charged on top, and a customer-service record that has not kept up with the product.

Overview

Ro is one of the largest and best-capitalised companies in US direct-to-consumer telehealth. It operates nationally, covering weight management alongside sexual health, fertility, hair, skin and general wellness, and it owns more of its own supply chain than almost any competitor we review — its own pharmacy operation and diagnostics rather than an unnamed third-party compounder.

That vertical integration is the substantive difference between Ro and most of the providers on this site. When we criticise a cheap programme for refusing to name its compounding pharmacy, the concern is that nobody is accountable for what is in the vial. Ro largely removes that question by selling manufacturer-made, FDA-approved products.

Ro at a Glance

How It Works, Step by Step

1. Start for $39. You pay $39 to begin, which Ro says is refunded if you turn out not to be eligible.
2. Online intake. A health questionnaire covering history, medications and goals.
3. Provider review. A licensed provider assesses eligibility and, where appropriate, prescribes.
4. Choose your medication. Wegovy pill or pen, Zepbound KwikPen, or Foundayo, priced by dose.
5. Membership begins. After the first month, membership renews at $149 monthly, or less if you commit to 3, 6 or 12 months upfront.
6. Delivery and ongoing care. Medication ships, with provider support, dose adjustments and side-effect management included in the membership.

Pricing: Membership Plus Medication

Ro charges in two parts, and both need adding together. These figures are from Ro's own pricing page on 6 August 2026.

Membership

Medication, priced by dose

Two things stand out. First, these are FDA-approved medications — Wegovy, Zepbound and Foundayo are manufacturer products, not compounded preparations. Second, the entry prices are genuinely competitive: $149 for the Wegovy pill matches what Novo Nordisk charges directly through NovoCare Pharmacy, and undercuts a great many compounded programmes.

Note also that several prices are flagged as limited-time offers, and that medication price rises with dose. Both matter for budgeting: the $199 Wegovy pen applies at starting doses, and becomes $349 once you titrate to 1mg and above. That is a $150 monthly increase most people will hit within a few months.

What You Will Actually Pay

Adding the two parts together is the only honest way to compare Ro with anything else.

Billing and Cancellation Complaints

Ro's complaint profile is unusually consistent, and it is almost entirely commercial rather than clinical. Reporting on its BBB record indicates that billing disputes account for roughly 60% of complaints, and three specific issues recur:

• Charges before prescription approval. Customers report being billed before a provider had approved treatment.
• Difficulty cancelling auto-renewal. The most frequently repeated complaint across both BBB and Trustpilot.
• Refund denials after shipping delays. Particularly on compounded semaglutide orders during the period Ro sold them.

Reviewers also cite advertising they found misleading and a membership cost they had not fully registered before signing up — which is consistent with a two-part price where the smaller, medication-only number does the marketing work. Read the membership tier carefully at checkout and know your renewal date. If you are prepaying for a year, that is a decision to make deliberately, not one to arrive at by clicking the cheapest per-month figure.

Eligibility, Contraindications, and Side Effects

Eligibility is assessed at intake by a licensed provider, and Ro refunds the $39 start fee if you are found ineligible — a fair term, and better than the many providers that keep a consultation fee regardless. Ro operates nationwide. See our eligibility guide for what a proper screen covers.

Semaglutide and tirzepatide carry a boxed warning regarding thyroid C-cell tumours, based on rodent studies. You should not take these medications if you or a family member have had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious hypersensitivity reaction to the active ingredient. They are not for use in pregnancy. A history of pancreatitis, gallbladder disease, gastroparesis or other severe gastrointestinal disease, or diabetic retinopathy, all warrant discussion before starting. Orforglipron (Foundayo) is a newer oral GLP-1 with a shorter real-world track record than semaglutide or tirzepatide — worth raising with the prescriber if it is offered to you.

Common side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation and abdominal pain, typically worst after a dose increase. Less common but serious risks include pancreatitis, gallbladder disease and acute kidney injury from dehydration. Our side effects guide covers management, and dose adjustment support is included in Ro's membership, which is one of the things you are paying for.

Legitimacy, Credentials, and Complaint Record

Ro's legitimacy is not in question. It has operated since 2017, is one of the most heavily funded companies in US telehealth, runs its own pharmacy and diagnostics, and dispenses FDA-approved medication from manufacturers. Nothing here resembles the anonymous-compounder risk profile that dominates the cheap end of this market.

Customer sentiment is split in the now-familiar pattern. On Trustpilot, Ro holds around 3.7 out of 5 across roughly 2,308 reviews, with praise for sign-up speed, easy approval, discreet packaging and fast shipping. On the BBB, customer reviews average about 1.19 out of 5 across roughly 111 reviews — a very low score from a much smaller, complaint-weighted sample.

The honest reading is that Ro delivers medication reliably and handles money badly. If everything goes smoothly you will likely be satisfied; if you need to change or cancel something, expect friction. For a company of Ro's size and funding, that is a choice rather than a constraint, and it is the main thing keeping this rating out of the fours.

How Ro Compares

The interesting comparison is Ro against the compounded market it used to belong to. At $223 all-in on an annual plan, Ro delivers an FDA-approved oral semaglutide for less than Willow charges for a compounded one, and for a modest premium over Cora Health's $99 compounded programme. Given that compounded GLP-1s face an unresolved FDA proposal on 503B bulk compounding, paying a little more for an approved product with a manufacturer behind it is a defensible trade — arguably the best argument for Ro on this page.

Against NovoCare, Ro costs more but includes the prescriber, ongoing support and dose management. If you already have a doctor willing to write the prescription, NovoCare is cheaper. If you do not, Ro is doing real work for the difference.

Pros and Cons

Who Should Pick It, and Who Should Look Elsewhere

Ro is a strong choice if you want an FDA-approved GLP-1 rather than a compounded one, you do not have a prescriber of your own, and you are comfortable committing to a longer membership term to get the rate down. For someone who wants the Wegovy pill with clinical support included and no compounding questions to worry about, $223 all-in on an annual plan is a reasonable deal in this market. The insurance support and the refundable start fee are both genuine positives.

Look elsewhere if you already have a prescriber — NovoCare Pharmacy sells the same FDA-approved medication for $149 with no membership. Look elsewhere if you want the lowest possible price and accept compounded medication, where Cora Health at $99 all-inclusive is far cheaper. And think hard before prepaying twelve months to a company whose defining complaint is difficulty cancelling — if you are unsure, pay month-to-month for the first cycle and accept the higher rate while you find out how the service treats you.

Limitations of This Review

This review is based on Ro's own published pricing page, its BBB profile and independent review platforms, checked on 6 August 2026. Several medication prices are marked as limited-time offers and may have changed by the time you read this. Cancellation terms are not clearly published, so our description of them relies on customer reports rather than stated policy. We have not signed up, been prescribed, or received medication. Insurance outcomes vary by plan and we have not tested Ro's insurance handling. This review also corrects our January 2026 version, whose $945–$1,345 medication figures no longer reflect Ro's pricing.

Frequently Asked Questions

Verdict

Ro has done the thing we keep asking this market to do: sell approved medication, from a manufacturer, at a price ordinary people can pay. At $223 all-in for the Wegovy pill on an annual plan, with a prescriber and dose management included, it is a genuinely good option and a clear improvement on where it stood at the start of the year. What stops it going higher is entirely self-inflicted — a two-part price that flatters the headline, a best rate that requires twelve months upfront, and a billing operation that generates a 1.19 BBB average at a company with no excuse for it. Buy the medicine; watch the subscription.